Filing
Spy
Filing
Spy
Home
About
AVIR
Atea Pharmaceuticals Inc
Clinical-stage biopharmaceutical company
CUSIP: 04683R106
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2021 Q3
1 of 1 quarters
Total Value
$58.03M
Total Shares
1.66M
Net Share Change
+1.66M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$58.03M
1.66M
0.2%
NEW
Viking Global Investors
$58.03M
1.66M shares
NEW
AVIR — Atea Pharmaceuticals Inc - FilingSpy